ConductScience.org, home

Trial · NCT06890897

Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia

NCT06890897, Not applicable, Recruiting, Beijing Tiantan Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia. Trials, record NCT06890897. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06890897

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia
NCT number
NCT06890897
Status
Recruiting
Phases
Not applicable
Enrollment
174 participants, estimated
Lead sponsor
Beijing Tiantan Hospital
Conditions
Zoster; Herpes, Trigeminal Neuralgia (Etiology)
Interventions
Esketamine group, PRF group
First posted
2025-03-24
Last updated
2025-04-27

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarythe NRS score at 1 month after treatment.1-month period
The Numeric Rating Scale (NRS) score is a way to quantify the degree of subjective feelings such as pain using numbers. Generally, 0 represents no pain, and 10 represents the most severe pain.A higher score indicates more severe pain
Secondarythe 12-item Short-Form Health Survey (SF-12) scoreat 1 day, 1 week, 2 weeks, 1 month, 2 months, 3 months after treatmentQuality of life (QoL) assessed by the SF-12 score (range 0-100, with higher scores indicating better health status)
Secondarythe Pittsburgh Sleep Quality Index (PSQI) scoreat 1 day, 1 week, 2 weeks, 1 month, 2 months, 3 months after treatmentSleep quality measured by PSQI score(range 0-21, with higher scores indicating poorer sleep quality)
Secondarythe Patient Global Impression of Change scale (PGIC)at 1 day, 1 week, 2 weeks, 1 month, 2 months, 3 months after treatmentThe proportion of patients with a response of "no change", "minimally improved", "much improved" or "very much improved" on PGIC
SecondaryAnalgesics consumptionat 1 day, 1 week, 2 weeks, 1 month, 2 months, 3 months after treatmentthe type of analgesics and analgesics consumption
SecondarySafety assessmentsat 0 day, 1 day, 1 week, 2 weeks,1 month, 2 months, 3 monthsintraoperative complications, PRF-related complications, Eskatamine-related complications

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06890897

GET https://conductscience.org/api/trials/v1/NCT06890897/registered